Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Schiff · SciRah

Researcher profile · Semantic Scholar

E. Schiff

Share profile

E. Schiff — researcher profile on SciRah

h-index: 85
Works: 482
Citations: 40K

Most-cited papers

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
N. Afdhal, K. Reddy, D. Nelson, E. Lawitz +21 more
2014New England Journal of Medicine1,366 citations
Semantic Scholar
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.
K. Kowdley, S. Gordon, K. R. Reddy, L. Rossaro +21 more
2014New England Journal of Medicine1,260 citations Open access
Semantic Scholar
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.
I. Jacobson, S. Gordon, K. Kowdley, E. M. Yoshida +19 more
2013New England Journal of Medicine1,171 citations Open access
Semantic Scholar
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
M. Charlton, G. Everson, Steven L. Flamm, Princy N. Kumar +26 more
2015Gastroenterology858 citations Open access
Semantic Scholar
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
M. Bourlière, S. Gordon, S. Flamm, C. Cooper +28 more
2017New England Journal of Medicine635 citations
Semantic Scholar
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
Michael P. Curry, X. Forns, Raymond T. Chung, Norah A. Terrault +20 more
2015Gastroenterology526 citations Open access
Semantic Scholar
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence
F. Poordad, E. Schiff, J. Vierling, Charles S. Landis +6 more
2016Hepatology480 citations Open access
Semantic Scholar
Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial
S. Gawrieh, M. Noureddin, N. Loo, R. Mohseni +8 more
2021Hepatology312 citations Open access
Semantic Scholar
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study
P. Kwo, N. Gitlin, R. Nahass, D. Bernstein +14 more
2016Hepatology210 citations Open access
Semantic Scholar
Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B.
E. Schiff, Samuel S. Lee, You C. Chao, Seung Kew Yoon +10 more
2011Clinical Gastroenterology and Hepatology170 citations Open access
Semantic Scholar
The current economic burden of cirrhosis.
G. Neff, C. Duncan, E. Schiff
2011Gastroenterology & hepatology165 citations
Semantic Scholar
Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog‐Treated or Untreated Patients During Chronic and Acute Infection
E. Butler, Jeffrey Gersch, A. Mcnamara, Ka-Cheung Luk +5 more
2018Hepatology149 citations
Semantic Scholar
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
P. Pockros, M. Fuchs, B. Freilich, E. Schiff +9 more
2019Liver international (Print)145 citations
Semantic Scholar
Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid.
Stephen R. Lee, K. Kardos, E. Schiff, C. A. Berne +16 more
2011Journal of Virological Methods144 citations
Semantic Scholar
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
T. Poynard, J. Vergniol, Y. Ngo, J. Foucher +13 more
2014Journal of Hepatology109 citations
Semantic Scholar
LO8 : Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: Phase 3 ALLY-1 study
F. Poordad, E. Schiff, J. Vierling, Charles S. Landis +6 more
2015103 citations
Semantic Scholar
Cost-effectiveness of screening for chronic hepatitis C infection in the United States.
M. Eckman, A. Talal, S. Gordon, E. Schiff +1 more
2011Clinical Infectious Diseases102 citations Open access
Semantic Scholar
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease
M. Shiffman, B. Freilich, R. Vuppalanchi, K. Watt +4 more
2018Alimentary Pharmacology and Therapeutics100 citations Open access
Semantic Scholar
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.
J. Bruix, T. Poynard, M. Colombo, E. Schiff +14 more
2011Gastroenterology100 citations Open access
Semantic Scholar
Long‐term clearance of hepatitis C virus following interferon α‐2b or peginterferon α‐2b, alone or in combination with ribavirin
M. Manns, P. Pockros, G. Norkrans, C. Smith +18 more
2013Journal of Viral Hepatitis79 citations
Semantic Scholar
LP14 : A phase 3, randomised, open-label study to evaluate the efficacy and safety of 8 and 12 weeks of simeprevir (SMV) plus sofosbuvir (SOF) in treatment-naïve and -experienced patients with chronic HCV genotype 1 infection without cirrhosis: Optimist-1
P. Kwo, N. Gitlin, R. Nahass, D. Bernstein +13 more
201575 citations
Semantic Scholar
Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics.
C. Levy, Jahnavi Naik, Christine Giordano, Amar Mandalia +4 more
2014Clinical Gastroenterology and Hepatology71 citations
Semantic Scholar
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial.
E. Lawitz, N. Reau, F. Hinestrosa, M. Rabinovitz +19 more
2016Gastroenterology55 citations Open access
Semantic Scholar
Supersonic Shear Imaging and Transient Elastography With the XL Probe Accurately Detect Fibrosis in Overweight or Obese Patients With Chronic Liver Disease.
M. Yoneda, E. Thomas, S. Sclair, T. T. Grant +1 more
2015Clinical Gastroenterology and Hepatology48 citations
Semantic Scholar
Drug-induced cholestasis.
K. Bhamidimarri, E. Schiff
2013Clinical Liver Disease48 citations
Semantic Scholar
Hepatitis B Virus and DNA Stimulation Trigger a Rapid Innate Immune Response through NF-κB
M. Yoneda, J. Hyun, Silvia Jakubski, S. Saito +3 more
2016Journal of Immunology44 citations Open access
Semantic Scholar
Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules
Faizal Z. Asumda, Konstantinos E. Hatzistergos, D. Dykxhoorn, Silvia Jakubski +3 more
2018Differentiation; research in biological diversity42 citations Open access
Semantic Scholar
Viral hepatitis: past and future of HBV and HDV.
E. Thomas, M. Yoneda, E. Schiff
2015Cold Spring Harbor Perspectives in Medicine42 citations Open access
Semantic Scholar
The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease
M. Yoneda, E. Thomas, Y. Sumida, Yuichiro Eguchi +1 more
2014Hepatology39 citations Open access
Semantic Scholar
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.
M. Sulkowski, K. Agarwal, Xiao-Li Ma, Tuan T. Nguyen +31 more
2022Journal of Hepatology38 citations Open access
Semantic Scholar
LP37 : A placebo-controlled, multicenter, double-blind, randomised trial of emricasan in subjects with non-alcoholic fatty liver disease (NAFLD) and raised transaminases
M. Shiffman, B. Freilich, R. Vuppalanchi, K. Watt +4 more
201529 citations
Semantic Scholar
Viral eradication is required for sustained improvement of patient‐reported outcomes in patients with hepatitis C
Z. Younossi, M. Stepanova, R. Reddy, M. Manns +6 more
2018Liver international (Print)28 citations
Semantic Scholar
Effects of statins on the risk of hepatocellular carcinoma.
P. Mansourian, M. Yoneda, M. Rao, F. Martinez +2 more
2014Gastroenterology & hepatology26 citations
Semantic Scholar
Resistance-Associated Amino Acid Variants Associated with Boceprevir plus Pegylated Interferon-α2B and Ribavirin in Patients with Chronic Hepatitis C in the Sprint-1 Trial
R. Ogert, J. Howe, J. Vierling, P. Kwo +18 more
2013Antiviral Therapy25 citations
Semantic Scholar
Clinical usage of serum ferritin to assess liver fibrosis in patients with non‐alcoholic fatty liver disease: Proceed with caution
M. Yoneda, E. Thomas, Y. Sumida, Kento Imajo +6 more
2014Hepatology Research23 citations
Semantic Scholar
Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV–HIV Coinfected Liver Transplant Recipients
N. Terrault, K. Reddy, F. Poordad, Michael P. Curry +13 more
2014American Journal of Transplantation23 citations Open access
Semantic Scholar
Schiff's Diseases of the Liver: Schiff/Schiff's Diseases of the Liver
E. Schiff, W. Maddrey, M. Sorrell
201123 citations
Semantic Scholar
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.
K. Patel, M. Friedrich-Rust, Y. Lurie, M. Grigorescu +12 more
2011World Journal of Gastroenterology23 citations Open access
Semantic Scholar
Efficacy and safety of vebicorvir administered in virologically-suppressed patients with chronic hepatitis B virus infection.
Man-Fung Yuen, K. Agarwal, Xiao-Li Ma, Tuan T. Nguyen +31 more
2022Journal of Hepatology22 citations Open access
Semantic Scholar
LBO-06-Interim safety and efficacy results of the ABI-H0731 phase 2a program exploring the combination of ABI-H0731 with Nuc therapy in treatment-naive and treatment-suppressed chronic hepatitis B patients
Xiao-Li Ma, J. Lalezari, Tuan T. Nguyen, H. Bae +28 more
2019Journal of Hepatology21 citations
Semantic Scholar
Overall safety profile of boceprevir plus peginterferon alfa‐2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials
M. Manns, J. Mccone, Mitchell N. Davis, L. Rossaro +19 more
2014Liver international (Print)20 citations
Semantic Scholar
An Update on the Hepatitis E Virus
S. Sclair, E. Schiff
2013Current Gastroenterology Reports20 citations
Semantic Scholar
Viral Hepatitis: Past and Future of Hepatitis B Virus and Hepatitis D Virus
E. Thomas, M. Yoneda, E. Schiff
201418 citations
Semantic Scholar
Combined Central Retinal Vein and Central Retinal Artery Occlusions and Neovascular Glaucoma Associated with Interferon Treatment
A. Rachitskaya, Richard K. Lee, S. Dubovy, E. Schiff
2012European Journal of Ophthalmology17 citations
Semantic Scholar
Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations
I. Jacobson, F. Poordad, R. Brown, P. Kwo +2 more
2012Journal of Viral Hepatitis17 citations
Semantic Scholar
Diagnosing and treating hepatitis C virus infection.
E. Schiff
2011American Journal of Managed Care17 citations
Semantic Scholar
Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis
Ethan Weinberg, Michael P. Curry, C. Frenette, F. Regenstein +6 more
2020Liver transplantation15 citations
Semantic Scholar
High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals
E. Lawitz, K. Kowdley, Michael P. Curry, N. Reau +23 more
201614 citations
Semantic Scholar
Randomized, Double‐Blind, Placebo‐Controlled, Single Ascending Dose Trial of Synthetic Preimplantation Factor in Autoimmune Hepatitis
C. O'Brien, E. Barnea, Paul L. Martin, C. Levy +5 more
2018Hepatology Communications13 citations Open access
Semantic Scholar
Barriers to Hepatitis C Screening in a Minority Population: A Comparison of Hepatitis C and Human Immunodeficiency Virus Screening Rates at a Community STD Clinic in Miami, Florida
Erica B. Feldman, R. Balise, E. Schiff, N. Whitehead +1 more
2017Journal of community health13 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Kwo×10
Invite
P. Kwo — researcher profile on SciRah
J. Mchutchison×9
Invite
J. Mchutchison — researcher profile on SciRah
I. Jacobson×9
Invite
I. Jacobson — researcher profile on SciRah
E. Thomas×9
Invite
E. Thomas — researcher profile on SciRah

×8

Invite

S. Gordon — researcher profile on SciRah

Invite

R. Nahass — researcher profile on SciRah

Invite

E. Lawitz — researcher profile on SciRah

Invite

M. Yoneda — researcher profile on SciRah

Invite

Z. Younes — researcher profile on SciRah

G. Subramanian×6

Invite

G. Subramanian — researcher profile on SciRah

H. Dvory‐Sobol×5

Invite

H. Dvory‐Sobol — researcher profile on SciRah

M. Sulkowski×5

Invite

M. Sulkowski — researcher profile on SciRah